41
CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

  • Upload
    reuel

  • View
    39

  • Download
    0

Embed Size (px)

DESCRIPTION

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease. General Data:. Name: Baby Boy G Neonate born of a 22 year old primigravida. History of the Present Illness. Initial prenatal check-up 6 th month of pregnancy at local health center CBC, urinalysis normal - PowerPoint PPT Presentation

Citation preview

Page 1: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

CARDIOVASCULAR CONFERENCE: Approach to a patient with

cyanotic heart disease

Page 2: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

General Data:

• Name: Baby Boy G• Neonate• born of a 22 year old primigravida

Page 3: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

History of the Present Illness

• Initial prenatal check-up– 6th month of pregnancy at local health center– CBC, urinalysis normal– UTZ: single live intrauterine pregnancy, cephalic,

good cardiac and somatic activity, 24-25 weeks AOG, rule out hypoplastic right ventricle.

– Referred to USTH

Page 4: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

HPI

• USTH (October 2010)– Fetal 2D- Echocardiogram: hypoplastic Left

Ventricle, hypoplastic Mitral Valve, and a patent foramen ovale

– (+) Trichomoniasis• 26-27 weeks AOG• Metronidazole 500mg/tab for 7 days

– (+) UTI• 37-38 weeks AOG• Cefuroxime 500mg BID for 7 days

Page 5: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

HPI

• The mother came in our institution for follow up

• 3 cm dilated, 70% effaced intact BOW, there was progression of labor alongside with spontaneous rupture of BOW.

• Clear, non-foul smelling amniotic fluid• Repeat fetal 2D echo was not done due to lack

of funds

Page 6: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Maternal History

• (-) exposure to radiation• (-) symptoms of viral exanthems• (-) use of illicit drugs and abortifacients • Non-smoker• Non drinker of alcoholic beverages• (-) hypertension, allergy, thyroid disease, diabetes,

asthma, liver disease, or blood dyscrasia – Hep B screening non-reactive– OGCT normal

Page 7: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Family HistoryName Age Relation Educational

AttainmentOccupation Health

MPG 22 Mother 2nd year nursing student

Student Healthy

LG 23 Father High school graduate

Unemployed Healthy

Page 8: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Family History

• No diabetes, hypertension, allergies• Denies hereditary illnesses

Page 9: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Physical Examination

• General Data– live, term, singleton, male, delivered via normal

spontaneous delivery– BW 2.75 kg, BL 48 cm– AS 6 and 7 at 5 minutes, MT 38-39 weeks AOG– AGA

Page 10: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Physical Examination on Admission

• HR 134 bpm, RR 58 cpm, T 37.2˚C • Blue, pale; some flexion of extremities, good

respiratory effort, cyanotic • (-) Rash, (-) birth marks,• (+) Molding, (+) caput succedaneum (-)

cephalhematoma• (+) ROR OU, (-) eye discharge, normal set ears, (-)

preauricular pits, patent nares, (-) Epstein’s pearls

Page 11: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Physical Examination on Admission• (-) Palpable neck masses, intact clavicle, no crepitations• (-) Chest deformities, symmetrical chest expansion, (-) retractions,

clear and equal breath sounds • Adynamic precordium, regular heart rate and rhythm, grade 1

holosystolic murmur • Globular abdomen, (+) umbilical stump with 2 arteries and 1 vein,

(-) organomegaly, (-) palpable masses• Grossly male, bilaterally descended testes, good rugae, patent anus • Femoral pulses full and equal, (-) Barlow, (-) Ortolani• Straight spine, (-) sacral dimpling, (-) tuft of hair• (+) Moro, grasp, rooting, plantar, and sucking reflexes

Page 12: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

APPROACH TO DIAGNOSIS OF A PATIENT PRESENTING WITH CYANOSIS AT BIRTH

Page 13: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Indicators that heart disease may exist

• Cyanosis• Cardiomegaly (Radiologic or Pericardial bulge)• Pathologic heart murmur• Tachypnea or overt respiratory distress (dyspnea)• Sweating especially during feeding• Increased or decreased pulses• Failure to thrive

Page 14: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Classification of Congenital Heart Diseases

A) Acyanotic

B) Cyanotic

Page 15: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Major Considerations

• Is there a shunt (LR or RL)• Is there obstruction to inflow or outflow• Abnormal heart valves• Abnormal connections of great vessels• Combination

Page 16: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Subgroups of Acyanotic Diseases

• Shunt anomalies• Valvular defects• Obstructive lesions• Inflow anomalies• Primary myocardial diseases

Page 17: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Shunt Anomalies

• L R shunt• Increased pulmonary blood flow• Increased pulmonary vascular arterial

markings on chest Xray

• ASD, VSD, PDA

Page 18: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Obstructive Lesion

• Discrepancy in amplitude of the peripheral pulses

• Coarctation of the Aorta

Page 19: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Inflow Anomalies

• Increased pulmonary venous markings on chest Xray

• No murmur

• Cor Triatriatum, Pulmonary vein stenosis

Page 20: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Valvular Defects

• Stenosis or regurgitant• Characteristic murmur

• AS, AR, PS, PR, MS, MR, TS, TR

Page 21: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Primary Myocardial Diseases

• No murmur• Disparity between cardiac size and pulmonary

vascular markings

• Glycogen storage disease• Cardiomyopathy

Page 22: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Hemodynamic Consequences

A) Volume (Diastolic) overload

B) Pressure (Systolic) overload

Page 23: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

ASD

Hemodynamic Consequence

Diastolic overload of RV

Page 24: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

VSD• Hemodynamic

Consequence• MODERATE SIZE

– Volume overload of LV

• LARGE SIZE– Volume overload of

LV– Pressure overload of

RV

Page 25: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Cyanotic Heart Disease

• Cyanotic heart disease exist when one defect or association of defects allow the mixture of saturated and de-saturated blood to reach the systemic circulation

Page 26: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Do you suspect that patient is Cyanotic?

• When in doubtA) ClubbingB) CBCC) Hyperoxia test

Page 27: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Hyperoxia Test

• Hyperoxia test is considered positive for intracardiac shunting if PO2 < 150 mmHg (torr) after 10 minutes of 100% fiO2

Page 28: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

PVA / IVS• Hemodynamic

Consequence

• Pressure overload of RV

Page 29: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

PVA / VSD• Hemodynamic

Consequence

• Pressure overload of RV

Page 30: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

PDA Dependent Pulmonary Circulation

• Pulmonary valve atresia (PVA) with intact interventricular septum

• Other lesions with accompanying PVA

Page 31: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Approach to diagnosis

A) Chest Xray Increased or decreased pulmonary vascular arterial markings

B) EKG RVH, LVH, CVH

C) Character of second heart sound

S2 single, loudS2 single, normalSplit S2

Page 32: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Chest x-ray

Page 33: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Causes of Cyanosis

Noncardiac Cardiac

•Pulmonary disorders (structural abnormalities of the lung, ventilation-perfusion mismatching, congenital or acquired airway obstruction, pneumothorax, hypoventilation)•Abnormal forms of hemoglobin (methemoglobin)•Poor peripheral perfusion (sepsis, hypoglycemia, dehydration, hypoadrenalism)•primary or persistent pulmonary hypertension

Increased pulmonary vascularity•D-TGA•TAPVR without obstruction•PTA•Single ventricle•DORV w/o PS•PPHN

Decreased pulmonary vascularity•TOF•Ebstein’s anomaly•PS•PA•TA with PS•DORV with PS

Page 34: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Pulmonary Vascular MarkingsDecreased: Cyanotic

TOF Tricuspid Atresia

Complex heart with PS PVA / IVS

Page 35: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Second Heart Sound (S2)

Single Loud Single Normal Split S2

TGA TOF TAPVR without obstruction

Aortic / Mitral atresia

Tricuspid atresia

Truncus Arteriosus

PVA

Page 36: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Cardiac Work-Up

A) EKGB) Chest XrayC) 2D echocardiography

(TTE, TEE, ICE, IVUS)D) Cardiac catheterizationE) CT angiography, cardiac MRI

Page 37: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

• PLACE THE:– ECG– 2-D ECHO

Page 38: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Modalities of Management

A) PharmacologicB) Catheter based therapyC) Surgical

Page 39: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Pharmacologic

A) digoxin, diuretics, inotropes (pressor), vasodilators

B) Prostaglandin

Page 40: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Catheter Based Therapy (DI KO PA ALAM ITO, EXAMPLES LANG TO)

A) Balloon atrio septostomy (Rashkind)B) Balloon valvuloplastyC) Balloon angioplastyD) Delivery of occlusion devicesE) Radio frequency ablation

Page 41: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Surgical (DI KO PA ALAM ITO, EXAMPLES LANG TO)

A) Shunts like Modified Blalock-TaussigB) PA bandC) Complete repairD) Glenn, FontanE) NorwoodF) Jatene, Mustard, Senning